Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.


Controversy Surrounding ROCKET-AF: A Call for Transparency, But Should We Be Changing Practice?


Arrhythmia & Electrophysiology Review 2016;5(1):12–3

Pacing and Defibrillators in Complex Congenital Heart Disease


Arrhythmia & Electrophysiology Review 2016;5(1):57–64

Periodic Repolarisation Dynamics Assessment for Risk Prediction


Arrhythmia & Electrophysiology Review 2016;5(1):31–6

Post-extrasystolic Potentiation: Link between Ca2+ Homeostasis and Heart Failure?


Arrhythmia & Electrophysiology Review 2016;5(1):20–6